Feedback / Questions
pimicotinib (ABSK021) - Abbisko, EMD Serono
https://www.manilatimes.net/2025/06/10/tmt-newswire/pr-newswire/abbisko-therapeutics-announces-china-nmpa-acceptance-of-new-drug-application-for-pimicotinib-for-the-treatment-of-tgct/2130296
Jun 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next